Corticotropin-releasing hormone1 receptors mediate consensus interferon-α YM643-induced depression-like behavior in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 292, Issue 1, 2000, Pages 181-187

  Yamano, Mayumi ^a,b   Yuki, Hidenobu ^a   Yasuda, Syuhei ^a   Miyata, Keiji ^a  

^a Inst for Drug Discovery Research   (Japan)

^b Inst for Drug Discovery Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA1 INTERFERON; CONSENSUS INTERFERON; CORTICOTROPIN RELEASING FACTOR RECEPTOR; IMIPRAMINE; INDOMETACIN; NALOXONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; HORMONAL REGULATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; IMIPRAMINE; INDOMETHACIN; INTERFERON-ALPHA; MALE; MICE; MOTOR ACTIVITY; NALOXONE; NARCOTIC ANTAGONISTS; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; TIME FACTORS;

EID: 0033984198     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 1, assessed in hamsters. J Interferon Res 6:405-415.
2. Amir S (1982) Involvement of endogenous opioids with forced swimming-induced immobility in mice. Physiol Behav 28:249-251.
3. Blatt LM, Davis JM, Klein SB and Taylor MW (1996) The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon. J Interferon Cytokine Res 16:489-499.
4. Calabrese JR, Skwerer RG, Barna B, Gulledge AD, Valenzuela R, Butkus A, Subichin S and Krupp NE (1986) Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 17:41-47.
5. Catalan R, Gallart JM, Castellanos JM and Galard R (1998) Plasma corticotropin-releasing factor in depressive disorders. Biol Psychiatry 44:15-20.
6. Crnic LS and Segall MA (1992) Prostaglandins do not mediate interferon-alpha effects on mouse behavior. Physiol Behav 51:349-352.
7. Curtis AL and Valentine RJ (1994) Corticotropin-releasing factor neurotransmission in locus coeruleus: A possible site of antidepressant action. Brain Res Bull 35:581-587.
8. Fadda P, Pani L, Porcella A and Fratta W (1995) Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain. Neurosci Lett 192:121-123.
9. Galeotti N, Ghelardini C, Caldari B and Bartolini A (1999) Effect of potassium channel modulators in mouse forced swimming test. Br J Pharmacol 126:1653-1659.
10. Gisslinger H, Svoboda T, Clodi M, Gilly B, Ludwig H, Havelec L and Luger A (1993) Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro. Neuroendocrinology 57:489-495.
11. Gold PW, Licinio J, Wong ML and Chrousos GP (1995) Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs. Ann NY Acad Sci 771:716-729.
12. Grisel JE, Fleshner M, Watkins LR and Maier SF (1993) Opioid and nonopioid interactions in two forms of stress-induced analgesia. Pharmacol Biochem Behav 45:161-172.
13. Holmes SW and Trim JL (1985) A re-examination of the actions of prostaglandins E1, E2, F1alpha and D2 administered intracerebroventricularly to cats. Br J Pharmacol 84 (Suppl):36P.
14. Levenson JL and Fallon HJ (1993) Fluoxetine treatment of depression caused by interferon-alpha. Am J Gastroenterol 88:760-761.
15. Little JS Jr, Goode RL and Neubauer BL (1995) Prenatal in vivo bulbourethral gland development is not affected by prostaglandin E2 inhibition. J Androl 16:5-11.
16. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB and Oltersdorf T (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92:836-840.
17. Lundkvist J, Chai Z, Teheranian R, Hasanvan H, Bartfai T, Jenck F, Widmer U and Moreau JL (1996) A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. Eur J Pharmacol 309:195-200.
18. Maes M, Bosmans E, Meltzer HY, Scharpe S and Suy E (1993) Interleukin-1 beta: A putative mediator of HPA axis hyperactivity in major depression? Am J Psychiatry 150:1189-1193.
19. Makino M, Kitano Y, Hirohashi M and Takasuna K (1998) Enhancement of immobility in mouse forced swimming test by treatment with human interferon. Eur J Pharmacol 356:1-7.
20. Makino M, Kitano Y, Komiyama C and Takasuna K (1997) Involvement of CNS opioid system in interferon-induced depression in mice. Jpn J Pharmacol 73 (Suppl 1):171P.
21. Malaguarnera M, Di Fazio I, Restuccia S, Pistone G, Ferlito L and Rampello L (1998) Interferon alpha-induced depression in chronic hepatitis C patients: Comparison between different types of interferon alpha. Neuropsychobiology 37:93-97.
22. Mansbach RS, Brooks EN and Chen YL (1997) Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist. Eur J Pharmacol 323:21-26.
23. Menzies RA, Patel R, Hall NRS, O'Grady MP and Rier SE (1992) Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes. Life Sci 50:PL227-PL232.
24. Mitchell AJ (1998) The role of corticotropin releasing factor in depressive illness: A critical review. Neurosci Biobehav Rev 22:635-651.
25. Mogil JS, Sternberg WF, Balian H, Liebeskind JC and Sadowski B (1996) Opioid and nonopioid swim stress-induced analgesia: A parametric analysis in mice. Physiol Behav 59:123-132.
26. Nakajima M, Inui A, Teranishi A, Miura M, Hirosue Y, Okita M, Himori N, Baba S and Kasuga M (1993) Effects of pancreatic polypeptide family peptides on feeding and learning behavior in mice. J Pharmacol Exp Ther 268:1010-1014.
27. Ohdo S, Koyanagi S, Yukawa E and Higuchi S (1997) Circadian rhythm of fever induced by interferon-alpha in mice. Life Sci 61:PL95-PL100.
28. Otsubo T, Miyaoka H, Kamijima K, Onuki M, Ishii M and Mitamura K (1997) Depression during interferon therapy in chronic hepatitis C patients - A prospective study. Psychiat Neurol Jpn 99:101-127.
29. Perrault GH, Morel E, Zivkovic B and Sanger DJ (1992) Activity of litoxetine and other serotonin uptake inhibitors in the tail suspension test in mice. Pharmacol Biochem Behav 42:45-47.
30. Primus RJ, Yevich E, Baltazar C and Gallager DW (1997) Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsycopharmacology 17:308-316.
31. Raber J, Koob GF and Bloom FE (1997) Interferon-alpha and transforming growth factor-beta 1 regulate corticotropin-releasing factor release from the amygdala: Comparison with the hypothalamic response. Neurochem Int 30:455-463.
32. Schulz DW, Mansbach RS, Sprouse J, Braselton JP, Collins J, Corman M, Dunaiskis A, Faraci S, Schmidt AW, Seeger T, Seymour P, Tingley FD III, Winston EN, Chen YL and Heym J (1996) CP-154,526: A potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc Natl Acad Sci USA 93:10477-10482.
33. Serrano MI, Serrano JS, Fernandez A, Asadi I and Serrano-Martino MC (1998) GABA(B) receptors and opioid mechanisms involved in homotaurine-induced analgesia. Gen Pharmacol 30:411-415.
34. Shuto H, Kataoka Y, Horikawa T, Fujihara N and Oishi R (1997) Repeated interferon-α administration inhibits dopaminergic neural activity in the mouse brain. Brain Res 747:348-351.
35. Steru L, Chermat R, Thierry B and Simon P (1985) The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology 85:367-370.
36. Tachikawa E, Kondo Y, Takahashi M, Kashimoto T, Yanagihara N, Toyohira Y and Izumi F (1997) Interferon-α reduces catecholamine secretion from bovine adrenal chromaffin cells stimulated by acetylcholine. Naunyn-Schmiedeberg's Arch Pharmacol 356:699-705.
37. Tanaka T, Kawakami Y, Tanaka A, Tamura A and Miyazaki S (1997) Effects of repeated administration of interferon on behavior and serotonin positive neurons in the raphe nucleus in rats. J Tokyo Women's Med College 67:55-68.
38. Tong MJ, Reddy KR, Lee WM, Pockros PJ, Hoefs JC, Keeffe EB, Hollinger FB, Hathcote EJ, White H, Foust RT, Jensen DM, Krawitt EL, Fromm H, Black M, Blatt LM, Klein M, Lubina J and the consensus interferon study group (1997) Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial. Hepatology 26:747-754.
39. Valentine AD, Meyers CA and Talpaz M (1995) Treatment of neurotoxic side effects of interferon-alpha with naltrexone. Cancer Invest 13:561-566.
40. Xia Z, DePierre JW and Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34:27-37.